Abstract: A method for manufacturing an antiviral pharmaceutical composition for the prophylaxis or treatment of a rhinovirus infection that includes the utilization of iota-, kappa- or lambda-carrageenan or mixtures thereof.
Type:
Grant
Filed:
December 4, 2007
Date of Patent:
October 9, 2012
Assignee:
Marinomed Biotechnologie GmbH
Inventors:
Andreas Grassauer, Eva Prieschl-Grassauer, Christiane Koller, Alexander Pretsch